MCMCB Pro
J0666

J0666Injection, bupivacaine liposome, 1 mg

HCPCSActiveBETOS O1E

J0666 is a HCPCS Level II code for injection, bupivacaine liposome, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J0666 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
266 units
MAI 2 — Date of Service Edit: Policy · Anatomic Consideration
outpatient
266 units
MAI 2 — Date of Service Edit: Policy · Anatomic Consideration
DME supplier
266 units
MAI 2 — Date of Service Edit: Policy · Anatomic Consideration

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J0666

Long descriptor
Injection, bupivacaine liposome, 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, bupivacaine liposome

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2025

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0666

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0666 is not quite right, the correct code is very often within a few positions of it.

  • J0640Injection, leucovorin calcium, per 50 mg
  • J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg
  • J0642Injection, levoleucovorin (khapzory), 0.5 mg
  • J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg
  • J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
  • J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
  • J0654Injection, liothyronine, 1 mcg
  • J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
  • J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
  • J0670Injection, mepivacaine hydrochloride, per 10 ml
  • J0675Injection, carboprost tromethamine, 0.1 mg
  • J0681Injection, ceftobiprole medocaril sodium, 3 mg
  • J0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
  • J0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
  • J0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
  • J0690Injection, cefazolin sodium, 500 mg

Questions about J0666

What is HCPCS code J0666?

J0666 is a HCPCS Level II code for injection, bupivacaine liposome, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0666?

The CMS HCPCS file marks J0666 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0666 paid under the physician fee schedule?

J0666 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026